| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.06 | 0.3 |